OrthoPediatrics (KIDS) Stock Price & Analysis
KIDS Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- MXN 14.98B
- Enterprise Value
- MXN 598.83M
- Total Cash (Recent Filing)
- MXN 44.23M
- Total Debt (Recent Filing)
- MXN 98.36M
- Price to Earnings (P/E)
- ―
- Beta
- N/A
- Next Earnings
- Mar 10, 2027 (Est.)
- EPS Estimate
- -3.97
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth And Gross Margins
Sustained revenue expansion alongside consistently high gross margins indicates strong demand for the pediatric-focused portfolio and meaningful product economics. This combination gives OrthoPediatrics resources to invest in commercial expansion, innovation, and surgeon adoption while supporting scalable growth.
Specialized Market Position And Product Adoption
Deep adoption across children's hospitals and surgeon networks can reinforce OrthoPediatrics' specialized market position. Products that achieve broad hospital penetration may increase recurring implant utilization, strengthen contracting leverage, and help pull through related legacy products over multiple years.
Improving EBITDA And Cash Flow Outlook
The combination of improving EBITDA, positive quarterly free cash flow, and a stated path toward sustained positive FCF suggests operating leverage is beginning to emerge. If execution continues, stronger internal cash generation could reduce funding pressure and support continued product and set investment.
Bears Say
Persistent Net And Operating Losses
Despite strong sales growth and narrowing losses, the company has not yet demonstrated durable earnings power. Persistent operating and net losses can constrain internally funded investment, leave profitability sensitive to expense growth, and make future performance dependent on continued operating leverage.
Unproven Cash Flow Consistency
The recent shift to positive operating and free cash flow is encouraging but follows multiple years of negative operating cash flow. Limited consistency means cash generation may not yet reliably fund growth investments, set deployments, and operating needs without execution remaining strong.
Delayed Commercialization Of Growth Products
The timing of major product launches creates a multi-quarter gap between investment and meaningful revenue contribution. Delayed commercialization could defer expected growth, margin, and cash-flow benefits, leaving near-term results more reliant on the existing portfolio and continued execution in current channels.
OrthoPediatrics News
KIDS FAQ
What is OrthoPediatrics’s market cap?
When is OrthoPediatrics’s upcoming earnings report date?
How were OrthoPediatrics’s earnings last quarter?
Is OrthoPediatrics overvalued?
Does OrthoPediatrics pay dividends?
What is OrthoPediatrics’s EPS estimate?
What happened to OrthoPediatrics’s price movement after its last earnings report?
Which hedge fund is a major shareholder of OrthoPediatrics?
What is the TipRanks Smart Score and how is it calculated?
OrthoPediatrics Stock Smart Score
Company Description
OrthoPediatrics
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- David R. Bailey
- Employees
- 602
- Website
- www.orthopediatrics.com
- Address
- 2850 Frontier Drive, Warsaw, IN, 46582, US
OrthoPediatrics (KIDS) Earnings & Revenues
KIDS Earnings Call
Earnings Call SentimentPositive
The call was strongly positive, with record revenue, 19% quarterly growth, a raised full-year revenue outlook, record adjusted EBITDA, positive quarterly free cash flow, strong demand across core businesses, and substantial progress in product launches and clinic expansion. The main challenges were that many super-cycle products remain in limited launch, eLLi commercialization is largely a 2028-2029 opportunity, year-to-date free cash flow remains negative, and operating expenses and commissions increased. Overall, the breadth and magnitude of the reported growth and management's confidence outweighed the timing and investment-related challenges.
View all MX:KIDS earnings summaries